Resources>Blog>Immunofluorescence

Immunofluorescence

Biointron 2024-01-20 Read time: 2 mins
Principle-for-direct-and-indirect-immunofluorescence-assay-Figure.jpg
Image credit: DOI: 10.3384/diss.diva-170740

Immunofluorescence (IF) is an immunochemical staining technique that utilizes fluorochrome-labeled antibodies for the visualization and localization of targets, by labelling with a fluorescent dye such as fluorescein isothiocyanate (FITC). It can identify a wide range of components on tissue sections, cultured cells, or individual cells, and is thus highly valuable for their broad capability with the use of combinations of specific antibodies tagged with fluorophores.

There are several steps for IF, with the first being fixation to immobilize target antigens while maintaining cellular architecture. Next, sample preparation and blocking needs to be carried out to prevent non-specific binding of antibodies. Then, incubation of primary and secondary antibodies take place before the final preservation and imaging.

There are two different IF methods available: Direct (Primary) and Indirect (Secondary). Direct detection requires using a single fluorochrome-conjugated primary antibody. Meanwhile, indirect detection uses two antibodies, with the first being an unlabeled primary antibody, followed by a fluorochrome-conjugated secondary antibody.

Although both monoclonal and polyclonal antibodies can be used for IF, they have their own pros and cons. Indirect IF more commonly used as the secondary antibodies are typically polyclonal, allowing for the recognition of multiple epitopes of the targets. However, monoclonal antibodies which are specifically designed for IF may be more preferable if your research involves recognizing very specific targets.1

At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.


References:

  1. Im, K., Mareninov, S., Diaz, M. F. P., & Yong, W. H. (2019). An introduction to Performing Immunofluorescence Staining. Methods in Molecular Biology (Clifton, N.J.), 1897, 299. https://doi.org/10.1007/978-1-4939-8935-5_26

Subscribe to our Blog
Recommended Articles
Roundup of Antibody Biotech Deals in March 2026

March 2026 saw a surge in antibody dealmaking, focusing on T-cell engagers and a……

Apr 01, 2026
Why Antibody Programs Fail Early: Reducing Attrition in Drug Development

Clinical drug development remains associated with a high failure rate, primarily……

Mar 30, 2026
NextGen Biomed 2026 – London: Highlights and Event Recap

Read on for the key trends of the NextGen Biomed 2026 conference held in London ……

Mar 25, 2026
2026 Networking Lunch Recap: “At the Table: Antibody Discovery”

Biointron’s Networking Lunch (At the Table: Antibody Discovery) was held at Cata……

Mar 17, 2026

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.